MethaCholine Bronchoprovocation Study (MeCIS)

PHASE4CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Asthma
Interventions
DRUG

fluticasone

Inhaled corticosteroid approved for treatment of asthma

Trial Locations (13)

10016

New York Consortium/Columbia University, New York

10595

New York Medical College, Valhalla

11040

Long Island Jewish Medical Center, New Hyde Park

32207

The Nemours Children's Clinic, Jacksonville

33136

University of Miami/Univestiy of South Florida, Miami

43210

Ohio State University, Columbus

46202

Indiana University, Indianapolis

60611

Northwestern University Memorial Hospital, Chicago

64108

University of Missouri-Kansas City, Kansas City

70112

Louisianna State University, New Orleans

92103

University of California at San Diego, San Diego

631110

Washington University School of Medicine, St Louis

05405

Vermont Lung Center at the University of Vermont, Burlington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

collaborator

St. Louis University

OTHER

collaborator

Long Island Jewish Medical Center

OTHER

collaborator

North Shore University Hospital

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

University of Vermont

OTHER

collaborator

Nemours Children's Clinic

OTHER

collaborator

University of Florida

OTHER

collaborator

Indiana University

OTHER

collaborator

Ohio State University

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

University of Missouri-Columbia

OTHER

collaborator

Northwestern University

OTHER

collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

collaborator

University of Miami

OTHER

collaborator

University of South Florida

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

National Jewish Health

OTHER

collaborator

Duke University

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER